Form 4: Intellia Therapeutics Executive Sells Shares for Tax Obligations

Intellia Therapeutics' VP, Chief Accounting Officer, Michael P. Dube, sold 2,503 shares of common stock at $9.95 per share to cover tax withholding obligations related to RSU vesting.

Summary

• Michael P. Dube, the Vice President and Chief Accounting Officer of Intellia Therapeutics, Inc. (NTLA), reported a transaction involving the company's common stock.
• On July 2, 2025, Mr. Dube disposed of 2,503 shares of Intellia Therapeutics common stock.
• The shares were sold at a price of $9.95 per share.
• This transaction was a mandatory "sell-to-cover" to satisfy tax withholding obligations incurred upon the vesting of Restricted Stock Units (RSUs) on July 1, 2025.
• The sale was explicitly stated as not being a volitional trade by Mr. Dube.
• Following this transaction, Mr. Dube beneficially owns 57,137 shares of Intellia Therapeutics common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-volitional tax-related sale, which does not indicate a change in management's confidence or company performance, thus resulting in a neutral sentiment.

Positives

• The sale of shares by Michael P. Dube was a mandatory "sell-to-cover" transaction to satisfy tax withholding obligations, indicating it was not a discretionary sale based on a negative outlook on the company's prospects.

Negatives

• The transaction resulted in a reduction of 2,503 shares from the beneficial ownership of a key executive.

Future Outlook

NA

Management Comments

• "Represents a mandatory 'sell-to-cover' transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 1, 2025, and does not represent a volitional trade by the Reporting Person."

Industry Context

NA

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but the non-volitional nature of the sale mitigates concerns about management confidence.

Key Dates

Keywords

Intellia Therapeutics, NTLA, Form 4, Insider Transaction, Stock Sale, Executive Compensation, RSU, Tax Withholding, Michael Dube